Regulation of Opioid and Cannabinoid Receptor Genes in Human Neuroblastoma and T Cells by the Epigenetic Modifiers Trichostatin A and 5-Aza-2’-Deoxycytidine

By  

Neuroimmunomodulation, Vol. 19, Iss. 3, 2012-01 ,pp. : 180-186

Karger

Access to resources Recommend Favorite

Upregulation of Transient Receptor Potential Vanilloid Type-1 Receptor Expression in Oral Lichen Planus

By  

Neuroimmunomodulation, Vol. 17, Iss. 2, 2009-11 ,pp. : 103-108

Karger

Access to resources Recommend Favorite

Prospective Relationship between Hemispheric Lateralisation and CD4+ T Cells in Human Immunodeficiency Virus Type 1

By  

Neuroimmunomodulation, Vol. 21, Iss. 1, 2013-10 ,pp. : 31-36

Karger

Access to resources Recommend Favorite

The Novel Somatostatin Receptor 2/Dopamine Type 2 Receptor Chimeric Compound BIM-23A758 Decreases the Viability of Human GOT1 Midgut Carcinoid Cells

By  

Neuroendocrinology, Vol. 98, Iss. 2, 2013-07 ,pp. : 128-136

Karger

Access to resources Recommend Favorite

Dopamine D₂-Receptor Activation Differentially Inhibits N- and R-Type Ca²⁺ Channels in Xenopus Melanotrope Cells

By  

Neuroendocrinology, Vol. 80, Iss. 6, 2005-05 ,pp. : 368-378

Karger

Access to resources Recommend Favorite